1. a) Bruer H, Treuner UD (1974) US Pat 3855211; b) Rieche A, Martin D, Schade W (1963) Arch Pharm 296: 770; c) Schorr M, Duerckheimer W, Klatt P, Laemmler G, Nesemann G, Schrinner E (1969) Arzneim-Forsch 19: 1807; d) El-Shorbagi AN (2000) Arch Pharm 333: 28; e) Hanefeld W (1977) Arch Pharm 310: 409; f) Hussein MA, Shorbagi E, Khallil AR (2001) Arch Pharm 334: 305; g) Aboul-Fadl T, Hussein MA, El-Shorbagi AN, Khallil AR (2002) Arch Pharm 335: 438
2. a) Warshawsky A, Rogachev I, Patil Y, Baszkin A, Weiner L, Gressel J (2001) Langmuir 17: 5621; b) Farbwerke HAG (1970) Fr Pat 2015026; c) Schorr M, Duerckheimer W, Behrendt L, Duewel D (1971) Ger Pat 1 947 746; d) Nishimura K, Yasunaga T, Kanada S, Katayama S (1978) Jpn Pat 53-029932; e) Ciba-Geigy AG (1972) Br Pat 1301032; f) Henkel (1970) Fr Pat 1600071; g) Simsek R, Safak C, Erol K, Vural K (1999) Tr J Med Sc 29: 627; h) Orlinskii MM, Zimenkovskii BS (1998) J Pharma Chem 32: 516; i) Strogonova LT, Bolshakova SA, Tuzhilkova TN, Amosova SV, Ivanova NI, Tarasova OA, Alpert ML (1990) J Pharm Chem 24: 3
3. a) St. Georgiev V (1983) Survey of Drug Research in Immunologic Disease. In: Karger S (ed) Basel 1: 403; b) Bouzinac RM, De La Bastide RM, Charbonnier CJ, Musset M (1986) Eur Pat 179: 694; c) Gale GR (1991) Drugs Future 6: 225
4. a) Dhooghe M, De Kime N (2006) Tetrahedron 62: 513; b) Fernandez JMG, Mellet CO, Blanco JLJ, Mota JF, Gadelle A, Coste-Sarguet A, Defaye J (1995) Carbohy Res 268: 57
5. a) Mukerjee AK, Ashare R (1991) Chem Rev 91: 1; b) Boas U, Jakobsen MH (1995) J Chem Soc Chem Commun 1995; c) Elgemeie GH, Sayed SH (2001) Synthesis 1747; d) Boas U, Gertz H, Christensen JB, Heegaard PMH (2004) Tetrahedron Lett 45: 269